Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Autobahn Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Autobahn Therapeutics

Autobahn Therapeutics

Autobahn Therapeutics: A regenerative medicine company revitalizing health for CNS disorder patients.

HQ
San Diego, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Autobahn Therapeutics was founded with the mission to improve the health and quality of life for individuals affected by central nervous system (CNS) disorders. The company focuses on harnessing the regenerative power of the human body to develop next-generation therapies aimed at restoring brain health. Autobahn Therapeutics targets both rare and prevalent CNS diseases, striving to create innovative regenerative medicines that can significantly impact patient outcomes.

Notable affiliated individuals and investors include leading experts in regenerative medicine and prominent venture capital firms specializing in biotech. Autobahn Therapeutics has achieved key milestones in advancing its therapeutic pipeline, demonstrating promising preclinical results. The company's work has the potential to transform treatment paradigms for CNS disorders, offering new hope to patients and contributing to the broader field of regenerative medicine.

Autobahn Therapeutics - Similar Companies

Pipeline Therapeutics logo

Pipeline Therapeutics

Abata Therapeutics logo

Abata Therapeutics

abatatx.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Bolden Therapeutics logo

Bolden Therapeutics

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Axial Therapeutics logo

Axial Therapeutics

Caeregen Therapeutics logo

Caeregen Therapeutics

caeregen.com

Cell Reprogramming & Therapeutics logo

Cell Reprogramming & Therapeutics

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

ReNetX Bio logo

ReNetX Bio

renetx.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Regennova logo

Regennova

regennova.com

Camino Pharma logo

Camino Pharma

caminopharma.com

Myrobalan Therapeutics logo

Myrobalan Therapeutics

myrotx.com

Endogena Therapeutics logo

Endogena Therapeutics

Autobahn Therapeutics - Quick Facts

Who are Autobahn Therapeutics' competitors?

Companies similar to Autobahn Therapeutics include Pipeline Therapeutics, Abata Therapeutics, Juventas Therapeutics and Bolden Therapeutics.

When was Autobahn Therapeutics founded?

Autobahn Therapeutics was founded in 2017.

Where is Autobahn Therapeutics' headquarters located?

Autobahn Therapeutics' headquarters is located in San Diego, CA, US.

When was Autobahn Therapeutics' last funding round?

Autobahn Therapeutics' most recent funding round was for $32.7M (USD) in September 2022.

How much has Autobahn Therapeutics raised to-date?

As of Sep 8, 2022, Autobahn Therapeutics has raised a total of $108.7M (USD).

How many employees does Autobahn Therapeutics have?

Autobahn Therapeutics has 25 employees as of Feb 4, 2024.

Autobahn Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Regenerative Medicine
Tags
  • Biotech Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified